September 12, 2023
Dr. Courtney Young, Co-founder and CEO of MyoGene, was listed as one of MIT Technology Review’s 35 Innovators under 35 in Biotechnology 2023. She is recognized for her dedication that stems from her personal connection to muscular dystrophy and ongoing work in MyoGene to advance development of a cutting-edge therapy for Duchenne muscular dystrophy. We are grateful to MIT Technology Review for this recognition!
Read more here: